Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Trial to Assess the Tolerability of AVANZ® Salsola Immunotherapy

NCT02065856 is registered in ClinicalTrials.gov with ALK-Abelló A/S as lead sponsor.

NCT NCT02065856
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02065856 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Trial to Assess the Tolerability of AVANZ® Salsola Immunotherapy
Lead sponsor
ALK-Abelló A/S
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2013
Completion date
December 31, 2014
Enrollment
51 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allergic rhinoconjunctivitis due to salsola kali pollen